Treatment of the sexually dangerous patient.
D000328:Adult; D000726:Androgen Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004992:Ethics, Medical; D006801:Humans; D007258:Informed Consent; D008297:Male; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010262:Paraphilic Disorders / Q000188:drug therapy*; D013739:Testosterone / Q000378:metabolism
D000726:Androgen Antagonists; D003692:Delayed-Action Preparations; D013739:Testosterone; D008525:Medroxyprogesterone